The Effects of Propolis on Viral Respiratory Diseases

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2023 Jan 8

PMID 36615554

Authors

Marcin Ozarowski

Tomasz M Karpinski

Affiliations

Soon will be listed here.

Abstract

Propolis remains an interesting source of natural chemical compounds that show, among others, antibacterial, antifungal, antiviral, antioxidative and anti-inflammatory activities. Due to the growing incidence of respiratory tract infections caused by various pathogenic viruses, complementary methods of prevention and therapy supporting pharmacotherapy are constantly being sought out. The properties of propolis may be important in the prevention and treatment of respiratory tract diseases caused by viruses such as severe acute respiratory syndrome coronavirus 2, influenza viruses, the parainfluenza virus and rhinoviruses. One of the main challenges in recent years has been severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing COVID-19. Recently, an increasing number of studies are focusing on the activity of various propolis preparations against SARS-CoV-2 as an adjuvant treatment for this infection. Propolis has shown a few key mechanisms of anti-SARS-CoV-2 action such as: the inhibition of the interaction of the S1 spike protein and ACE-2 protein; decreasing the replication of viruses by diminishing the synthesis of RNA transcripts in cells; decreasing the particles of coronaviruses. The anti-viral effect is observed not only with extracts but also with the single biologically active compounds found in propolis (e.g., apigenin, caffeic acid, chrysin, kaempferol, quercetin). Moreover, propolis is effective in the treatment of hyperglycemia, which increases the risk of SARS-CoV-2 infections. The aim of the literature review was to summarize recent studies from the PubMed database evaluating the antiviral activity of propolis extracts in terms of prevention and the therapy of respiratory tract diseases (in vitro, in vivo, clinical trials). Based upon this review, it was found that in recent years studies have focused mainly on the assessment of the effectiveness of propolis and its chemical components against COVID-19. Propolis exerts wide-spectrum antimicrobial activities; thus, propolis extracts can be an effective option in the prevention and treatment of co-infections associated with diseases of the respiratory tract.

Citing Articles

Effect of L. on Improving Insulin Secretory Capacity and Resistance in Elderly Patients Aged 80 Years Old or Older Who Develop Diabetes After COVID-19 Infection.

Gonda K, Hai T, Suzuki K, Ozaki A, Shibusa T, Takenoshita S Nutrients. 2025; 17(2.

PMID: 39861420 PMC: 11767592. DOI: 10.3390/nu17020290.

Chemical profile, antioxidant, antifungal, and cytotoxic activities of propolis from the stingless bee Tetragona clavipes.

Bergamini A, de Almeida Bergamini B, Pessoa I, de Sousa Cutrim T, Dos Santos T, Dos Santos M Braz J Microbiol. 2024; 56(1):251-262.

PMID: 39673050 PMC: 11885680. DOI: 10.1007/s42770-024-01591-9.

Isolation of phenolic compounds from eco-friendly white bee propolis: Antioxidant, wound-healing, and anti-Alzheimer effects.

Necip A, Demirtas I, Tayhan S, Isik M, Bilgin S, Turan I Food Sci Nutr. 2024; 12(3):1928-1939.

PMID: 38455224 PMC: 10916560. DOI: 10.1002/fsn3.3888.

Exosome-mediated regulation of inflammatory pathway during respiratory viral disease.

Gheitasi H, Sabbaghian M, Shekarchi A, Mirmazhary A, Poortahmasebi V Virol J. 2024; 21(1):30.

PMID: 38273382 PMC: 10811852. DOI: 10.1186/s12985-024-02297-y.

Plant-Derived Epi-Nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents.

Gabbianelli R, Shahar E, de Simone G, Rucci C, Bordoni L, Feliziani G Nutrients. 2023; 15(22).

PMID: 38004113 PMC: 10675658. DOI: 10.3390/nu15224719.

References

Berretta A, Duarte Silveira M, Condor Capcha J, de Jong D . Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19. Biomed Pharmacother. 2020; 131:110622. PMC: 7430291. DOI: 10.1016/j.biopha.2020.110622. View

Silva H, Francisco R, Saraiva A, Francisco S, Carrascosa C, Raposo A . The Cardiovascular Therapeutic Potential of Propolis-A Comprehensive Review. Biology (Basel). 2021; 10(1). PMC: 7823408. DOI: 10.3390/biology10010027. View

Zhou W, Yin A, Shan J, Wang S, Cai B, Di L . Study on the Rationality for Antiviral Activity of Flos Lonicerae Japonicae-Fructus Forsythiae Herb Chito-Oligosaccharide via Integral Pharmacokinetics. Molecules. 2017; 22(4). PMC: 6154603. DOI: 10.3390/molecules22040654. View

Richards F, Kodjamanova P, Chen X, Li N, Atanasov P, Bennetts L . Economic Burden of COVID-19: A Systematic Review. Clinicoecon Outcomes Res. 2022; 14:293-307. PMC: 9060810. DOI: 10.2147/CEOR.S338225. View

Cohen H, Varsano I, Kahan E, Sarrell E, Uziel Y . Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study. Arch Pediatr Adolesc Med. 2004; 158(3):217-21. DOI: 10.1001/archpedi.158.3.217. View

Sokolonski A, Fonseca M, Machado B, Deegan K, Araujo R, Umsza-Guez M . Activity of antifungal drugs and Brazilian red and green propolis extracted with different methodologies against oral isolates of Candida spp. BMC Complement Med Ther. 2021; 21(1):286. PMC: 8611924. DOI: 10.1186/s12906-021-03445-5. View

Balica G, Vostinaru O, Stefanescu C, Mogosan C, Iaru I, Cristina A . Potential Role of Propolis in the Prevention and Treatment of Metabolic Diseases. Plants (Basel). 2021; 10(5). PMC: 8144987. DOI: 10.3390/plants10050883. View

Kujumgiev A, Tsvetkova I, Serkedjieva Y, Bankova V, Christov R, Popov S . Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J Ethnopharmacol. 1999; 64(3):235-40. DOI: 10.1016/s0378-8741(98)00131-7. View

Ghosh S, Al-Sharify Z, Maleka M, Onyeaka H, Maleke M, Maolloum A . Propolis efficacy on SARS-COV viruses: a review on antimicrobial activities and molecular simulations. Environ Sci Pollut Res Int. 2022; 29(39):58628-58647. PMC: 9258455. DOI: 10.1007/s11356-022-21652-6. View

10.

Pourajam S, Kalantari E, Talebzadeh H, Mellali H, Sami R, Soltaninejad F . Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic. Front Cell Infect Microbiol. 2022; 12:784130. PMC: 8904895. DOI: 10.3389/fcimb.2022.784130. View

11.

Magnavacca A, Sangiovanni E, Racagni G, DellAgli M . The antiviral and immunomodulatory activities of propolis: An update and future perspectives for respiratory diseases. Med Res Rev. 2021; 42(2):897-945. PMC: 9298305. DOI: 10.1002/med.21866. View

12.

Zulhendri F, Perera C, Tandean S, Abdulah R, Herman H, Christoper A . The Potential Use of Propolis as a Primary or an Adjunctive Therapy in Respiratory Tract-Related Diseases and Disorders: A Systematic Scoping Review. Biomed Pharmacother. 2022; 146:112595. DOI: 10.1016/j.biopha.2021.112595. View

13.

Stahli A, Schroter H, Bullitta S, Serralutzu F, Dore A, Nietzsche S . In Vitro Activity of Propolis on Oral Microorganisms and Biofilms. Antibiotics (Basel). 2021; 10(9). PMC: 8472590. DOI: 10.3390/antibiotics10091045. View

14.

Wieczorek P, Hudz N, Yezerska O, Horcinova-Sedlackova V, Shanaida M, Korytniuk O . Chemical Variability and Pharmacological Potential of Propolis as a Source for the Development of New Pharmaceutical Products. Molecules. 2022; 27(5). PMC: 8911684. DOI: 10.3390/molecules27051600. View

15.

Chen C, Michaelis M, Hsu H, Tsai C, Yang K, Wu Y . Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication. J Ethnopharmacol. 2008; 120(1):108-11. PMC: 7127248. DOI: 10.1016/j.jep.2008.07.048. View

16.

Ozarowski M, Karpinski T, Alam R, Lochynska M . Antifungal Properties of Chemically Defined Propolis from Various Geographical Regions. Microorganisms. 2022; 10(2). PMC: 8880174. DOI: 10.3390/microorganisms10020364. View

17.

Khayyal M, El-Ghazaly M, El-Khatib A, Hatem A, de Vries P, el-Shafei S . A clinical pharmacological study of the potential beneficial effects of a propolis food product as an adjuvant in asthmatic patients. Fundam Clin Pharmacol. 2003; 17(1):93-102. DOI: 10.1046/j.1472-8206.2003.00117.x. View

18.

Jin X, Ren J, Li R, Gao Y, Zhang H, Li J . Global burden of upper respiratory infections in 204 countries and territories, from 1990 to 2019. EClinicalMedicine. 2021; 37:100986. PMC: 8343248. DOI: 10.1016/j.eclinm.2021.100986. View

19.

Yosri N, El-Wahed A, Ghonaim R, Khattab O, Sabry A, Ibrahim M . Anti-Viral and Immunomodulatory Properties of Propolis: Chemical Diversity, Pharmacological Properties, Preclinical and Clinical Applications, and In Silico Potential against SARS-CoV-2. Foods. 2021; 10(8). PMC: 8391193. DOI: 10.3390/foods10081776. View

20.

Ali A, Kunugi H . Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies. Molecules. 2021; 26(5). PMC: 7956496. DOI: 10.3390/molecules26051232. View